MaxCyte Inc Reports Strong Q3 2026 Revenue of $10.2 Million, Surpassing Estimates of $7.48 Million
Total Revenue Up 49% Year-over-Year as Core Business Grows 27% Related Stocks: MXCT ,
Total Revenue Up 49% Year-over-Year as Core Business Grows 27% Related Stocks: MXCT ,